Citation: Rs. Stern et al., ORAL PSORALEN AND ULTRAVIOLET-A LIGHT (PUVA) TREATMENT OF PSORIASIS AND PERSISTENT RISK OF NONMELANOMA SKIN-CANCER, Journal of the National Cancer Institute, 90(17), 1998, pp. 1278-1284
Citation: Rs. Stern et al., HIV-POSITIVE PATIENTS DIFFER FROM HIV-NEGATIVE PATIENTS IN INDICATIONS FOR AND TYPE OF UV THERAPY USED, Journal of the American Academy of Dermatology, 39(1), 1998, pp. 48-55
Citation: Ej. Lunder et Rs. Stern, MERKEL-CELL CARCINOMAS IN PATIENTS TREATED WITH METHOXSALEN AND ULTRAVIOLET-A RADIATION, The New England journal of medicine, 339(17), 1998, pp. 1247-1248
Citation: Rs. Stern et Ej. Liebman, BASAL-CELL CARCINOMA (BCC) IN THE 2ND DECADE OF THE PUVA FOLLOW-UP-STUDY, Journal of investigative dermatology, 110(2), 1998, pp. 21-21
Citation: Rs. Stern, MANAGED CARE AND THE TREATMENT OF SKIN-DISEASE, 1995 - CONTINUED GROWTH AND EMERGING DOMINANCE, Archives of dermatology, 134(9), 1998, pp. 1089-1091
Authors:
MORISON WL
BAUGHMAN RD
DAY RM
FORBES PD
HOENIGSMANN H
KRUEGER GG
LEBWOHL M
LEW R
NALDI L
PARRISH JA
PIEPKORN M
STERN RS
WEINSTEIN GD
WHITMORE SE
Citation: Wl. Morison et al., CONSENSUS WORKSHOP ON THE TOXIC EFFECTS OF LONG-TERM PUVA THERAPY, Archives of dermatology, 134(5), 1998, pp. 595-598
Citation: Ka. Arndt et Rs. Stern, ALTERNATIVE MEDICINE AND DERMATOLOGY - THE UNCONVENTIONAL ISSUE, Archives of dermatology, 134(11), 1998, pp. 1472-1472
Citation: Ke. Mckenna et Rs. Stern, THE IMPACT OF PSORIASIS ON THE QUALITY-OF-LIFE OF PATIENTS FROM THE 16-CENTER PUVA FOLLOW-UP COHORT, Journal of the American Academy of Dermatology, 36(3), 1997, pp. 388-394
Citation: Rs. Stern et Ke. Mckenna, THE OUTCOMES MOVEMENT AND NEW MEASURES OF PSORIASIS - REPLY, Journal of the American Academy of Dermatology, 36(3), 1997, pp. 503-503
Authors:
GOYAL S
ARNDT KA
STERN RS
OHARE D
DOVER JS
Citation: S. Goyal et al., LASER TREATMENT OF TATTOOS - A PROSPECTIVE, PAIRED, COMPARISON STUDY OF THE Q-SWITCHED ND-YAG (1064 NM), FREQUENCY-DOUBLED Q-SWITCHED ND-YAG (532 NM), AND Q-SWITCHED RUBY-LASERS, Journal of the American Academy of Dermatology, 36(1), 1997, pp. 122-125
Citation: Rs. Stern et al., MALIGNANT-MELANOMA IN PATIENTS TREATED FOR PSORIASIS WITH METHOXSALEN(PSORALEN) AND ULTRAVIOLET-A RADIATION (PUVA), The New England journal of medicine, 336(15), 1997, pp. 1041-1045
Citation: P. Tennis et Rs. Stern, RISK OF SERIOUS CUTANEOUS DISORDERS AFTER INITIATION OF USE OF PHENYTOIN, CARBAMAZEPINE, OR SODIUM VALPROATE - A RECORD LINKAGE STUDY, Neurology, 49(2), 1997, pp. 542-546
Authors:
STERN RS
VAKEVA LH
BAUER E
KOO J
EPSTEIN JH
WOLF J
NIGRA TP
ANDERSON TF
PRYSTOWSKY J
MCEVOY M
TAYLOR JR
ZAIAS N
URBACH F
ARNDT KA
BAUGHMAN RD
BRAVERMAN IM
MURRAY J
WERTH V
FITZPATRICK TB
PARRISH J
SOBER A
Citation: Rs. Stern et al., NONCUTANEOUS MALIGNANT-TUMORS IN THE PUVA FOLLOW-UP-STUDY - 1975-1996, Journal of investigative dermatology, 108(6), 1997, pp. 897-900
Citation: Rs. Stern, THE PATTERN OF TOPICAL CORTICOSTEROID PRESCRIBING IN THE UNITED-STATES, 1989-1991, Journal of the American Academy of Dermatology, 35(2), 1996, pp. 183-186
Citation: Ke. Mckenna et Rs. Stern, THE OUTCOMES MOVEMENT AND NEW MEASURES OF THE SEVERITY OF PSORIASIS, Journal of the American Academy of Dermatology, 34(3), 1996, pp. 534-538